References
- Glare P A, Walsh T D. Clinical pharmacokinetics of morphine. Ther Drug Monit 1991; 13: 1–23
- Hasselstrom J, Sawe J. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharmacokinet 1993; 24: 334–354
- Shimomura K, Kamata O, Ueki S, et al. Analgesia effect of morphine glucuronide. Tohoku J Exp Med, 105: 45–52
- Osborne R, Thompson P, Joel S, et al. The analgesic activity of morphine-6-glucuronide. Br J Clin Pharmacol 1992; 34: 130–138
- Gong Q L, Hedner J, Bjorkman R, et al. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992; 48: 249–255
- Portenoy R K, Thaler H T, Inturrisi G E, et al. The metabolite mor-phine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther 1992; 51: 422–431
- Bowsher D. Paradoxical pain when the metabolites of morphine are in the wrong ratio. Br Med J 1993; 306: 473–474
- Wallenstein S L, Houde R W. The clinical evaluation of analgesic effectiveness. Methods in Narcotic Research, S Ehrenpreis, A Neidle. Marcel Dekker, New York 1974; 127–145
- Joel S P., Osborne R J, Slevin M L. An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites. J Chromatogr 1988; 430: 394–399
- McQuay H J, Carroll D, Faura C C, et al. Oral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther 1990; 48: 236–244
- Osborne R J, Joel S P, Slevin M L. Morphine intoxication in renal failure: The role of morphine-6-glucuronide. Br Med J 1986; 292: 1548–1549
- Somogyi A A, Nation R L, Olweny C, et al. Plasma concentration and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Clin Pharmacokinet 1993; 24: 413–420
- Goucke C R., Hackett L P, Ilett K F. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain. Pain 1994; 56: 145–149